Amgen eyes potential acquisitions
Executive Summary
Amgen's consolidation of Immunex gives the company confidence that it could pursue other large agreements, CEO Sharer said Feb. 25, but "that doesn't mean we're just going to [do] it for the heck of it." While "acquisitions are something that we don't expect," Sharer says, "obviously, given that prices are much lower right now, we're looking harder." The CEO outlined Amgen's criteria for a takeover prospect, which include an ability to drive top-line growth and a fit with Amgen's culture...